BDBM406645 2-{5-[6-butyl-5- (2,6- dimethoxyphenyl)- 2,4-dihydroxy- pyridin- 3-yl]-1,3,4- oxadiazol- 2-yl}-N-[(3- chlorophenyl) methyl]acetamide::US10336739, Example 259::US10336739, Example 267

SMILES CCCCc1nc(O)c(-c2nnc(CC(=O)NCCc3ccc(Cl)cc3)o2)c(O)c1-c1c(OC)cccc1OC

InChI Key InChIKey=RWUPSJGCOFGHEA-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 406645   

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406645(US10336739, Example 267 | 2-{5-[6-butyl-5- (2,6- d...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetApelin receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM406645(US10336739, Example 267 | 2-{5-[6-butyl-5- (2,6- d...)
Affinity DataEC50:  5.5nMAssay Description:HEK293 cells stably expressing human APJ receptor were used to assess the activity of compounds. Cultured cells were detached and resuspended in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent